>>13840780 (pb notable)
Also in the middle of the Salton Sea quake swarm-
Synthetic Genomics, Inc. commercializes genomic-driven technologies. The Company develops biological solutions for fuel, advanced plant feedstocks, microbial agents for agriculture, and metabolic pathways for production of biochemicals. Synthetic Genomics operates in the United States.
https://www.bloomberg.com/profile/company/1024783Z:US
October 26, 2017 — Synthetic Genomics, Inc. is part of the recently funded DARPA Pandemic Prevention Platform (P3) program aimed at establishing a system capable of halting viral pandemics within 60 days. As part of the collaboration, led by Duke, Synthetic Genomics will contribute synthetic biology technologies to enable rapid delivery of anti-viral countermeasures.
The Duke Human Vaccine Institute has received a $12.8 million, 30-month grant from the U.S. Department of Defense, Defense Advanced Research Projects Agency (DARPA) to develop a system capable of halting viral pandemics within 60 days.
The program, called DARPA Pandemic Prevention Platform (P3), seeks to combine expertise in virology, immunology and clinical manufacturing to rapidly identify and respond to disease outbreaks such as SARS, pandemic influenza and Zika before they spread widely.
https://synbiobeta.com/synthetic-genomics-partners-duke-human-vaccine-institute/